Articles from Carterra

SALT LAKE CITY, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced the launch of the Carterra Vega™ High-Throughput Surface Plasmon Resonance (HT-SPR) instrument. The industry’s first 48-channel SPR platform, Vega delivers 12-fold higher throughput versus the market leading system for small molecule through large molecule discovery and development workflows.

Presentations will be delivered by experts from a wide variety of leading research groups including Pfizer, GSK, and Bio-Techne, along with co-hosts IPA, ACROBiosystems, and Curia.

Carterra’s latest instrument enables high-throughput small and large-molecule characterization in traditional and AI-driven workflows   

Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, launched its latest HT-SPR instrument, the LSAXT, at the Society for Laboratory Automation and Screening (SLAS) Conference and Exhibition in San Diego, CA. The LSAXT brings augmented sensitivity to Carterra’s highly successful LSA platform enabling additional applications throughout drug discovery and development at throughput levels unseen in any other instrument. Carterra will be showcasing the new LSAXT platform for high-throughput SPR at the SLAS event (booth 2127) with a launch program that includes a user presentation by Dragonfly Therapeutics on February 27 at 2:00 pm.

Ernst & Young LLP (EY) has selected Josh Eckman, CEO of Carterra, as a 2022 Entrepreneur of the Year® Mountain West Award winner. EY Entrepreneur of the Year is one of the preeminent competitive business awards for entrepreneurs and leaders of high-growth companies. An independent panel of judges selected Mr. Eckman based on his entrepreneurial spirit, purpose, growth, and impact, among other core contributions and attributes.

The University of Manchester, United Kingdom, and Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, announced today that the University of Manchester has added Carterra’s LSA instrument to its Biomolecular Analysis Core Facility (BACF) within the Faculty of Biology, Medicine and Health (FBMH).

Genovac, a leading contract research and manufacturing organization (CRO/CMO) that discovers, develops, and manufactures antibodies for therapeutic, diagnostic, and research market segments, and Carterra, Inc., the world leader in label-free high-throughput antibody screening and characterization, today announced that Genovac has acquired Carterra’s LSA platform for use in its discovery services.

Carterra, Inc. the world leader in label-free high throughput antibody screening and characterization, today announced that it has signed an exclusive Asia-Pacific and Oceania region distribution agreement with PerkinElmer, Inc. a global leader committed to innovating for a healthier world. With the agreement, PerkinElmer will market, sell, and service Carterra’s flagship LSA high-throughput surface plasmon resonance (SPR) platform and software used for accelerating the discovery of therapeutic antibodies.